Deferring Nail Mycological Sampling during the COVID-19 Pandemic: Recommendations from a Multidisciplinary Panel of Nail Specialists
Genre
Journal articleDate
2021-12-08Author
Lipner, Shari R.Ghannoum, Mahmoud
Hinshaw, Molly A.
Rich, Phoebe
Ruben, Beth S.
Vlahovic, Tracey
Scher, Richard K.
Department
Podiatric MedicineSubject
SARS-CoV-2COVID-19
Coronavirus
Pandemic
Onychomycosis
Fungal nail infection
Nail disease
Telemedicine
Nail clipping
DermoscopyOnychoscopyPotassium hydroxideMicroscopyFungal culturePolymerase chain reactionDermatologyPodiatryDermatopathologyMycology
Permanent link to this record
http://hdl.handle.net/20.500.12613/7277Metadata
Show full item recordDOI
https://doi.org/10.1159/000520628Abstract
Onychomycosis is the most common nail condition seen in clinical practice, with significant impact on quality of life. Clinical examination alone is insufficient for accurate diagnosis, but mycological confirmation can be challenging during the COVID-19 pandemic. In this letter, a multidisciplinary panel of dermatologists, a podiatrist, dermatopathologists, and a mycologist, discuss considerations for mycological sampling during the pandemic.Citation
Lipner SR, Ghannoum M, Hinshaw M, et al. Deferring Nail Mycological Sampling during the COVID-19 Pandemic: Recommendations from a Multidisciplinary Panel of Nail Specialists. Skin Appendage Disord. 2021. doi:10.1159/000520628Citation to related work
Karger PublishersHas part
Skin Appendange DisordersADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduScopus Count
Except where otherwise noted, this item's license is described as Attribution CC BY